Stay updated on Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page.

Latest updates to the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now displays a 403 Forbidden error, preventing access to the study record and its associated documents. This change hides the study details that were previously visible on the page.SummaryDifference19%

- Check26 days agoChange DetectedThe page revision label was updated to v3.7.0, signaling an update to the page. The study content and displayed information remain unchanged.SummaryDifference0.1%

- Check40 days agoChange DetectedA new revision tag (Revision: v3.6.6) appears on the page, replacing the prior v3.6.5, indicating a background site update.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision: v3.6.5 was added and Revision: v3.6.4 was removed, representing a minor update to the page's revision label. This change reflects an internal update to the page template or documentation without altering study details or user-visible content.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision tag changed from v3.6.3 to v3.6.4, representing an updated page build. This update does not modify the study details or content shown to users.SummaryDifference0.1%

- Check97 days agoChange DetectedThe page now displays Revision: v3.6.3, indicating a software version update. This reflects an update to the site infrastructure rather than changes to study data or visible content.SummaryDifference0.1%

Stay in the know with updates to Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page.